Cinfa B2B consolidates its international presence at the CPHI Frankfurt 2025 trade fair

Cinfa B2B has once again taken part in the leading global event for the pharmaceutical industry, the CPHI 2025 trade fair, held in Frankfurt. Our presence at this year’s event provided an opportunity for us to move strategic projects forward, strengthen international alliances and expand the reach of our value proposition in pharmaceutical out-licensing.

A space designed as a meeting point with our partners

Situated in Hall 3, in the designated finished product manufacturer area and surrounded by industry leaders, our 89 m² stand was designed to host high-value meetings. Equipped with nine meeting tables, this space remained a hub of activity during the three days of the event as we held over 182 meetings with customers and suppliers from across the globe. This strong participation highlights a growing interest in Cinfa B2B’s value proposition – a model that combines specialisation, quality and a comprehensive approach to the entire project life cycle.

A shared purpose at the heart of every collaboration

The meetings held during the event reinforce Cinfa B2B’s standing as a leading partner in international out-licensing projects and pave the way for new opportunities for collaboration. “Cinfa B2B’s participation in CPHI 2025 confirms our global partners’ trust and inspires us to continue delivering high-quality, accessible solutions that meet the demands of an ever-changing international landscape”. Jorge Moreno, Corporate Director, BD & Out-Licensing, Global B2B Division We are grateful to all the collaborators who visited our stand. This experience reinforces our commitment to maintain a strong presence at the sector’s major events, fostering relationships built on a shared intention: to offer quality health care that is accessible to everyone.